Board
of
Directors
Dr. David Genecov was a dedicated physician in the field of cleft lip and palate, craniofacial and pediatric plastic surgery. David had over 25 years of experience as a practicing surgeon, private investor, chief executive and director in both public and private companies. Dr. Genecov was Co-Founder and former director of AveXis, Inc. (NASDAQ: AVXS), acquired by Novartis in 2018 for $8.7 billion, which develops proprietary gene therapies for rare neurological genetic diseases. David also founded or co-founded numerous companies in the health care industry, including Skin Within, Inc., Synergy Surgical Services LLC, Biolife Cell Bank LLC and was the owner and director of The Modern Medical Spa. He was a director and investor of CerSci Therapeutics, a pharmaceutical company using non opioid approaches to treat pain, which was sold to Acadia Pharmaceuticals (NASDAQ: ACAD) in 2020 for up to $940 million. David was a director and co-founder of Cessation Therapeutics, Inc., a company based on the treatment of substance use disorders with monoclonal antibodies and vaccines. Formerly, Dr. Genecov served as the President and CEO of Dialectic Therapeutics, Inc., a Dallas-based precision oncology company using innovative new protein degradation technologies to treat cancer.
Bio